Arvinas, Inc. (ARVN) financial statements and ratios from SEC XBRL: revenue $262.60M (TTM), net margin -30.8%, revenue growth 1014.7% YoY, P/E 65.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $262.60M |
| Net Margin | -30.8% |
| Revenue Growth (YoY) | 1014.7% |
| EPS Growth (YoY) | -410.7% |
| FCF Growth (YoY) | -49.8% |
| P/E Ratio | 65.9 |
| Price / Book | 1.09 |
| Price / Sales | 1.93 |
| FCF Yield | -34.1% |
| Altman Z-Score | -1.12 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ARVN overview · ARVN earnings · ARVN KPIs · ARVN investor relations · ARVN ownership · ARVN peers · ARVN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.